Ego Pharmaceuticals does not use methylisothiazolinone (MI) in any products
Ego Pharmaceuticals today clarified that no Ego products contain methylisothiazolinone (also known as MI) and confirmed that this preservative has never before been used in any Ego products.
Dr Fabrizio Spada Ph.D, R&D Manager at Ego Pharmaceuticals released a statement today to put any public concern at ease.
“We would like to reassure you that Ego does not use methylisothiazolinone (MI) and we never have,” Dr Spada stated.
Restoring and maintaining skin health is a core value to Ego Pharmaceuticals which produces products of the highest quality, manufactured to Australian and international pharmaceutical standards.
“The preservative in question has been known to be a sensitiser to the skin for many years – deeming it inappropriate for our skincare products,” Dr Spada added.
About Ego Pharmaceuticals
In 1953, Ego Pharmaceuticals was founded by humble Melbourne chemist, Gerald Oppenheim, creating innovative skin care products from his Elsternwick laundry. With over 60 years of research and development, Ego is still led by members of the founding family, carrying on Gerald’s legacy and producing products of the highest quality, manufactured to Australian and international pharmaceutical standards.
With over 130 products, Ego’s well-known pharmacy brands include QV, SunSense, Aqium, SolvEasy and MOOV all created and manufactured in Australia.
Ego’s reputation has been built on consistently delivering effective, high-quality and innovative products backed by science. Today, Ego remains committed to creating quality skin therapies and everyday skincare products